WhatsApp
Prostate

Critical steps to optimize RARP

Critical Steps in Robotic Prostatectomy: How Can Outcomes Be Optimised?

Robotic surgery is a platform. The outcome depends on what the surgeon does with it.

A robotic surgical system provides magnified three-dimensional vision and highly mobile instruments. But simply using a robot does not automatically produce a good prostatectomy.

A quality robotic radical prostatectomy requires the surgeon to make a series of decisions before, during and after surgery that balance three goals:

Cancer control + functional preservation + patient safety

The operation should be planned around the individual patient’s cancer rather than performed as a standardized sequence in every patient.

What Defines a Good Robotic Prostatectomy?

A high-quality RARP should aim for:

The cancer must be removed adequately, with appropriate attention to surgical margins and pathological staging.

Where oncologically appropriate, the surgical plan should aim to preserve structures contributing to urinary continence and sexual function.

Important structures in the deep pelvis need to be identified and protected whenever possible.

Blood loss, transfusion, complications, readmission and reoperation should be minimized.

The operation should be evaluated not only by what happens in the operating room, but by PSA, cancer control, continence, sexual function and quality of life over time.

Good Outcomes Begin Before the Operation

The first critical step is not making the first incision.

It is understanding the cancer accurately.

Before surgery, the prostate cancer profile should be reviewed using the available clinical information.

This may include:

  • PSA and PSA trend
  • Prostate biopsy
  • Gleason score / ISUP Grade Group
  • Distribution and volume of cancer in biopsy cores
  • Multiparametric MRI
  • Clinical stage
  • PSMA PET/CT when indicated
  • Baseline urinary function
  • Baseline erectile function
  • Previous prostate procedures such as TURP
  • Previous hormonal treatment
  • General health and comorbidities

The objective is to answer:

Where is the cancer, how extensive is it, and what does that mean for the surgical plan?

MRI and Biopsy Should Be Interpreted Together

MRI provides anatomical information.

Biopsy provides pathological information.

Neither should be considered in isolation.

Before surgery, the surgeon should understand:

  • Which part of the prostate contains the dominant tumour
  • Whether the cancer appears confined to the prostate
  • Whether there is suspected extracapsular extension
  • Whether the tumour approaches the neurovascular bundle
  • Whether the apex is involved
  • Whether the seminal vesicles appear involved
  • Whether there are suspicious lymph nodes or other disease

The surgical plan can then be tailored to the individual cancer.

Decide the Oncological Extent of Surgery Before Deciding the Nerve-Sparing Plan

One of the most important principles of prostatectomy is:

Nerve preservation should follow oncological assessment — not replace it.

The surgeon should first determine how much tissue needs to be removed to achieve adequate cancer clearance.

Only then can the appropriate nerve-sparing strategy be planned.

This may result in:

  • Bilateral nerve-sparing
  • Unilateral nerve-sparing
  • Partial/graded preservation
  • Non-nerve-sparing dissection

The decision can differ between the two sides of the prostate.

Read more → Nerve-Sparing Robotic Prostatectomy

The Apex Requires Particular Attention

The prostate apex is an anatomically important region where cancer-control and functional considerations meet.

An overly aggressive dissection may compromise functional recovery.

An inadequate oncological dissection may increase the risk of a positive surgical margin.

The surgical objective is therefore: Precise apical dissection with appropriate cancer clearance while preserving functional anatomy whenever possible.

Urethral length and the external urinary sphincter are important considerations during apical dissection.

Preserve Urethral Length When Oncologically Appropriate

The urethra passes through the prostate and continues through the pelvic floor.

After the prostate is removed, the bladder has to be reconnected to the remaining urethra.

Where anatomy and cancer extent permit, preservation of functional urethral length can be an important component of the continence-preservation strategy.

This must be balanced against adequate removal of cancer at the apex.

Bladder-Neck Preservation or Reconstruction

The bladder neck is the junction between the bladder and prostate.

Depending on tumour location and anatomy, the bladder neck may be preserved or reconstructed after prostate removal.

The objective is to restore anatomy while maintaining adequate cancer clearance.

Bladder-neck management is therefore individualized rather than performed identically in every patient.

Posterior Reconstruction

After prostate removal, the anatomical support structures around the urethra and bladder outlet can be reconstructed as part of the surgical technique.

Posterior reconstruction is one of the techniques that may be used to restore pelvic anatomy and support the vesicourethral anastomosis.

Its use and exact technique depend on individual anatomy and surgical judgement.

A Precise Vesicourethral Anastomosis

After prostate removal, the bladder and urethra must be reconnected.

This is the vesicourethral anastomosis.

The reconstruction should aim to be:

  • Watertight
  • Tension-free
  • Anatomically aligned
  • Precise
  • Appropriate for the individual tissue quality and anatomy

A well-constructed anastomosis is important for safe urinary recovery and helps reduce complications such as urinary leakage.

Pelvic Lymph-Node Dissection Should Be Individualized

Pelvic lymph-node dissection is not required in every prostate cancer patient.

When indicated, the extent and anatomical template should be planned according to:

  • Risk of nodal involvement
  • PSA
  • Grade Group
  • Clinical stage
  • MRI
  • PSMA PET/CT where appropriate
  • Overall treatment strategy

The aim is appropriate pathological staging without unnecessary morbidity.

Read more → Pelvic Lymph-Node Dissection in Prostate Cancer

Minimize Unnecessary Tissue Trauma

The pelvis contains delicate nerves, vessels and supporting structures.

During robotic dissection, important principles include:

  • Precise tissue-plane identification
  • Gentle tissue handling
  • Avoidance of unnecessary traction
  • Appropriate use of energy devices
  • Protection of preserved neurovascular structures
  • Protection of major vessels
  • Maintaining clear anatomical orientation

Robotic magnification and wristed instruments can facilitate precise dissection, but the surgeon’s anatomical knowledge and technique remain fundamental.

Control Blood Loss Without Compromising the Operation

Blood loss is influenced by:

  • Patient anatomy
  • Prostate size
  • Vascular anatomy
  • Cancer extent
  • Pelvic lymph-node dissection
  • Previous procedures
  • Surgical technique

The aim is controlled dissection and haemostasis while avoiding unnecessary tissue injury.

In our analysed surgical series, average blood loss has been approximately 200 mL, with a transfusion rate of approximately 5%.

Previous Procedures Can Change the Operation

Not every prostatectomy is performed in an untouched pelvis.

Our practice includes patients with:

  • Previous TURP
  • Previous hormonal treatment
  • Previous pelvic procedures
  • Difficult pelvic anatomy
  • Large tumours
  • Locally advanced disease
  • Complex/reoperative pelvic situations

These patients may require modification of the usual surgical approach.

Previous procedures should therefore be identified during preoperative planning rather than discovered unexpectedly during surgery.

Complex Pelvic Anatomy Requires More Than Robotic Experience

Robotic prostatectomy is performed deep within the pelvis.

The surgeon must understand the relationship between:

  • Prostate
  • Bladder
  • Urethra
  • Neurovascular bundles
  • Rectum
  • Pelvic vessels
  • Obturator structures
  • Lymphatic tissue
  • Pelvic floor

This becomes particularly important in patients with advanced disease or previous pelvic procedures.

A surgeon’s experience in complex pelvic oncology, not simply robotic console experience, can therefore be relevant when managing difficult prostate cancer cases.

Cancer Control Must Remain the First Priority

Functional preservation should never result in leaving suspected cancer behind.

A surgeon may initially plan nerve preservation but modify the plan during surgery if the cancer requires wider excision.

Similarly:

  • A wider apical dissection may be necessary
  • A neurovascular bundle may need to be sacrificed
  • Bladder-neck preservation may not be appropriate
  • Additional tissue may need to be removed
  • Lymph-node dissection may be required

The correct operation is the one that provides appropriate cancer clearance while preserving function where it is oncologically safe.

What Is a Positive Surgical Margin?

A positive surgical margin means that cancer cells are present at the inked edge of the removed surgical specimen.

It does not automatically mean that the cancer will recur.

However, positive margins can be associated with a higher risk of biochemical recurrence and need to be interpreted along with:

  • Pathological stage
  • Grade Group
  • PSA
  • Seminal-vesicle involvement
  • Lymph-node status
  • Other pathological features

The aim of surgery is to achieve a negative surgical margin whenever possible without unnecessarily compromising functional preservation.

Our Analysed Surgical Experience

Dr Swati Shah has been performing robotic prostatectomy since 2013.

Her reported surgical experience includes:

627 – Robotic radical prostatectomies personally performed

650 – Total radical prostatectomies

~95% – Cases undergoing pelvic lymph-node dissection in the analysed series

~15 – Average lymph nodes retrieved

~10% – Positive surgical margins in the analysed series

~200 mL – Average blood loss

~5% – Transfusion rate

~2% – Major complications

~2% – Readmission

These figures represent surgeon-maintained clinical data and should be interpreted according to the specific cohort, definitions, case mix and duration of follow-up. Detailed oncological and functional outcomes are presented separately.

Functional Recovery Requires More Than Surgical Technique

Urinary continence and erectile function are influenced by multiple factors.

Continence

Important factors include:

  • Preoperative urinary function
  • Age
  • Prostate anatomy
  • Apical dissection
  • Urethral length
  • Bladder-neck management
  • Reconstruction
  • Pelvic-floor rehabilitation

Erectile Function

Important factors include:

  • Baseline erectile function
  • Age
  • Cardiovascular and metabolic health
  • Tumour location
  • Extent of cancer
  • Degree of nerve preservation
  • Postoperative rehabilitation

Therefore, a good operation should be considered part of a complete treatment and recovery pathway, rather than the end of treatment.

Early Mobilisation and Postoperative Care

Surgical outcome is also influenced by postoperative management.

Our postoperative pathway includes attention to:

  • Early mobilisation
  • Pain control
  • Catheter management
  • Nutrition
  • Prevention of complications
  • Pelvic-floor rehabilitation
  • Monitoring for urinary or lymphatic complications
  • PSA follow-up

In our analysed series, average postoperative hospital stay has been approximately 2.8 days.

Individual recovery varies according to disease extent, procedure complexity and patient health.

Long-Term Follow-Up Is Part of Surgical Quality

A prostatectomy should not be considered successful simply because the patient leaves the hospital without a complication.

Long-term follow-up should include:

Cancer control

  • PSA
  • Biochemical recurrence monitoring
  • Final pathology
  • Further treatment when indicated

Functional recovery

  • Urinary continence
  • Erectile function

Quality of life

  • Return to normal activities
  • Sexual health
  • Psychological and social recovery where support is needed

This is why long-term outcomes are more meaningful than the number of robotic operations alone.

Read more → Life After Robotic Prostatectomy: Cancer & Functional Outcomes

What Should Patients Ask a Surgeon Before Choosing Robotic Prostatectomy?

Instead of asking only: “Do you perform robotic prostatectomy?”

patients may consider asking:

About experience

  • How many robotic prostatectomies have you personally performed?
  • How long have you been performing robotic prostatectomy?
  • What proportion of your practice is prostate cancer surgery?

About cancer control

  • What is your positive surgical margin rate for comparable disease?
  • How do you manage high-risk and locally advanced disease?
  • When do you perform pelvic lymph-node dissection?

About functional outcomes

  • How do you approach nerve preservation?
  • What are your continence outcomes?
  • How do you assess erectile-function recovery?

About complex cases

  • Do you operate on T3/T4 or node-positive disease?
  • How do you approach patients with previous TURP or previous pelvic procedures?

About follow-up

  • How is PSA monitored?
  • What happens if PSA remains detectable or subsequently rises?
  • Is radiation or medical oncology available when required?

A transparent discussion is more useful than choosing a surgeon based only on the presence of a robotic system.

What Defines a Quality Robotic Prostatectomy?

A quality robotic prostatectomy is not defined by:

“There is a robot.”

It is defined by the entire pathway:

Right patient selection
↓
Accurate staging
↓
Individualized surgical planning
↓
Appropriate cancer clearance
↓
Functional preservation when safe
↓
Safe reconstruction
↓
Low complication burden
↓
Rehabilitation
↓
Long-term oncological and functional follow-up

Our Approach: Cancer Control Without Losing Sight of Quality of Life

Dr Swati Shah’s prostate cancer practice has focused on the combination of:

Uro-oncology + Robotic Surgery + Pelvic Oncology + Functional Preservation

Her experience includes management of:

  • Localized prostate cancer
  • Intermediate-risk disease
  • High-risk disease
  • Very-high-risk disease
  • T3/T4 disease
  • Node-positive disease
  • Large-volume tumours
  • Previous TURP
  • Previous hormonal treatment
  • Complex pelvic anatomy
  • Reoperative pelvic surgery

The aim is not to perform the same operation on every patient.

The operation is tailored to the cancer.

And within that oncological plan:

Every reasonable effort is made to preserve function.

See the Technique in Practice

Surgical Video

[FEATURED TECHNICAL RARP VIDEO] → Watch Robotic Prostatectomy Surgical Videos

Surgical Gallery

[FEATURED OPERATIVE shorts]

The robotic system provides a magnified, high-definition 3D view of the surgical field, allowing the surgeon to clearly identify delicate anatomical structures such as tiny blood vessels and important nerves. This enhanced visualization is particularly valuable during prostate surgery, where precise dissection is essential.

The system’s flexible wristed instruments can rotate and move with a range of motion that facilitates fine surgical movements in the confined pelvic space. This can help the surgeon perform accurate dissection while carefully working around critical structures.

The goal of robotic radical prostatectomy is to achieve complete cancer removal while, whenever oncologically appropriate, preserving important surrounding structures that contribute to urinary continence and sexual function.

रोबोटिक सिस्टम सर्जिकल क्षेत्र का मैग्निफाइड, हाई-डेफिनिशन 3D दृश्य प्रदान करता है, जिससे सर्जन छोटी रक्त वाहिकाओं और महत्वपूर्ण नसों जैसी नाजुक संरचनाओं को स्पष्ट रूप से पहचान सकते हैं। यह बेहतर विज़ुअलाइज़ेशन प्रोस्टेट सर्जरी में विशेष रूप से महत्वपूर्ण है, जहाँ सटीक तरीके से सर्जरी करना आवश्यक होता है।

सिस्टम के फ्लेक्सिबल रिस्टेड इंस्ट्रूमेंट्स कई दिशाओं में घूम और मुड़ सकते हैं, जिससे पेल्विस के सीमित स्थान में भी सर्जन को बारीकी से सर्जरी करने में मदद मिलती है। इससे महत्वपूर्ण संरचनाओं के आसपास सावधानीपूर्वक काम करते हुए सटीक डिसेक्शन किया जा सकता है।

रोबोटिक रैडिकल प्रोस्टेटेक्टॉमी का लक्ष्य कैंसर को पूरी तरह निकालना होता है। साथ ही, जहाँ कैंसर की स्थिति इसकी अनुमति देती है, वहाँ पेशाब पर नियंत्रण (urinary continence) और यौन कार्य (sexual function) में महत्वपूर्ण भूमिका निभाने वाली आसपास की संरचनाओं को सुरक्षित रखने का प्रयास किया जाता है।

The goal is to achieve a complete oncological resection while preserving as much functional anatomy as safely possible. Careful dissection can help maintain adequate urethral length, protect the external urinary sphincter, and preserve the nerves responsible for urinary and sexual function when oncologically appropriate.

Robotic surgery provides a magnified, high-definition three-dimensional view and wristed instruments that allow controlled, precise movements in this confined anatomical space. This can be particularly valuable during apical dissection, where even small differences in tissue planes and surgical technique can influence postoperative outcomes.

However, functional preservation should never compromise cancer clearance. The prostate and involved tissues must be removed completely with appropriate oncological margins based on the patient’s tumour characteristics.

Real Case

[FEATURED CASE — COMPLEX / T3 / PREVIOUS TURP / NERVE-SPARING] → View the complete case summary

Robotic Radical Prostatectomy for Prostate Cancer with Negative Margins and Early Recovery

Robotic Radical Prostatectomy For Prostate Cancer With Negative Margins And Early Recovery – Real Patient Case

A 67-year-old male presented with urinary urgency and a significantly elevated PSA level of 144.92 ng/ml. Diagnostic imaging and biopsy confirmed an acinar adenocarcinoma, demanding an urgent and highly precise surgical intervention to prevent potential systemic spread while managing the high biochemical risk.

Patient Experience

Read the experience of a patient treated for prostate cancer.

[FEATURED GOOGLE REVIEW] → Read Prostate Cancer Patient Reviews

Dr. Swati is a highly skilled Uro Oncologist in Ahmedabad, experienced in managing prostate cancer and performing robotic prostate cancer surgeries with excellent outcomes. Patients appreciate her detailed explanations, compassionate approach, and commitment to ensuring the best possible recovery. She and her team provide advanced care in uro-oncology, including robotic and minimally invasive surgeries for prostate and bladder cancers across Gujarat
Google Revirew 1
Sabir Mohammed
Patient
Dr. Swati Shah provides excellent prostate treatment in Ahmedabad. With her vast experience and advanced treatment approach, she ensures accurate diagnosis and personalized care for every patient. She explains the condition and treatment options clearly, which gives patients confidence and comfort during a difficult time. Her compassionate nature and professional expertise make her a trusted specialist for prostate treatment.
Google Revirew 1
Gordhanbhai Patel
Patient
Dr. Swati Shah treated my father for prostate cancer with great expertise and care. She guided us at every step, and her calm, reassuring approach gave us immense confidence. Truly the best doctor for uro-gynaec cancers in Ahmedabad – highly recommended
Google Revirew 1
patel Mehul
Patient

Frequently Asked Questions

The robotic platform provides magnified 3D visualization and articulated instruments, but outcomes depend on patient selection, surgeon technique, team experience and postoperative care. A robot by itself does not guarantee better cancer or functional outcomes.

There is no single step. Good outcomes result from appropriate staging and planning followed by precise oncological dissection, appropriate nerve and anatomical preservation, reconstruction, safe lymph-node management and postoperative follow-up.

No. Nerve preservation depends on the location and extent of cancer. Cancer clearance takes priority.

No. A positive margin is a pathological finding associated with an increased risk of recurrence, but its significance depends on the complete pathology and postoperative PSA. Further treatment is not automatically required in every patient.

Previous TURP can make the operation more technically challenging because normal tissue planes and anatomy may be altered. It does not automatically rule out robotic prostatectomy.

Selected patients with locally advanced or node-positive disease may undergo surgery as part of a multimodal treatment strategy. These decisions require individualized staging and multidisciplinary planning.

Blood loss varies with anatomy, prostate size, cancer extent, lymph-node dissection and surgical technique. In our analysed series, average blood loss has been approximately 200 mL.

Hospital recovery and return to normal activities vary. Urinary continence and erectile function may continue to improve over months after surgery.

The Bottom Line

A robotic prostatectomy is only as good as the planning, surgical technique, cancer control and follow-up behind it.

For each patient, the important questions are:

Is surgery appropriate?

How much cancer needs to be removed?

Can nerves and functional structures safely be preserved?

Are lymph nodes required?

How can complications be minimized?

How will cancer control and functional recovery be followed after surgery?

A high-quality prostate cancer programme should be able to answer all of these questions — not simply provide access to a robotic machine.

[REQUEST A PROSTATE CANCER SECOND OPINION]

[BOOK A CONSULTATION WITH DR SWATI SHAH]

Related Prostate Cancer Pages

What Is Robotic Radical Prostatectomy (RARP)?

Understand RARP, who may be suitable and what the operation involves.

Nerve-Sparing Robotic Prostatectomy

Understand how nerve preservation is planned and performed.

Pelvic Lymph-Node Dissection in Prostate Cancer

Understand when lymph nodes are removed and what pathological staging means.

Localized Prostate Cancer: Surgery vs Other Treatment Options

Compare surgery with active surveillance and radiation-based approaches.

Locally Advanced & Node-Positive Prostate Cancer: Where Does Surgery Fit?

Understand surgery within multimodal treatment.

Life After Robotic Prostatectomy: Cancer & Functional Outcomes

Explore PSA, cancer control, continence, erectile function and our analysed outcomes.

Rate this page

Get health updates from Dr Swati Shah on WhatsApp

Swasth Parivar: twice a month, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

dr swati shah - uro & gynec cancer surgeon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.